Journal profile · CLINICAL NEUROLOGY
JPAD-Journal of Prevention of Alzheimers Disease
ISSN 2274-5807 · eISSN 2426-0266 · EDITIONS SERDI · FRANCE
JPAD-Journal of Prevention of Alzheimers Disease: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 5.82; fully open access; APC about USD 4,060; median 87 days to acceptance (85 articles, last 24 months); 301 articles in 2025; indexed in SCIE and Scopus.
The latest issue on the journal's website is from December 2024 (Volume 11, Issue 6): the journal may have stopped publishing or moved platform in the last two years. Check its website before submitting.
Scope
Aims, scope and focus
JPAD-Journal of Prevention of Alzheimers Disease is published by EDITIONS SERDI and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments and Nutritional Studies and Diet, together about 60.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The JPAD Journal of Prevention of Alzheimer’Diseasewill publish reviews, original research articles and short reports to improve our knowledge in the field of Alzheimer prevention including: neurosciences, biomarkers, imaging, epidemiology, public health, physical cognitive exercise, nutrition, risk and protective factors, drug development, trials design, and heath economic outcomes.JPAD will publish also the meeting abstracts from Clinical Trial on Alzheimer Disease (CTAD) and will be distributed both in paper and online version worldwide.We hope that JPAD with your contribution will play a role in the development of Alzheimer prevention.
From the journal's Aims & Scope
Research area (LetPub): CLINICAL NEUROLOGY
Editor-in-chief Paul AisenPublisher website
Editorial board by country: 1 in mainland China (about 5%); most named United States 14, Mainland China 1, France 1, Spain 1, Canada 1 (19 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Dementia and Cognitive Impairment ResearchMedicine34.3%
- Alzheimer's disease research and treatmentsMedicine21.5%
- Nutritional Studies and DietMedicine4.4%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance4.1%
- Cancer-related cognitive impairment studiesMedicine3%
- Health, Environment, Cognitive AgingEnvironmental Science2.6%
- Frailty in Older AdultsMedicine2.5%
- Neurological Disease Mechanisms and TreatmentsNeuroscience2.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Clinical Neurology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Clinical Neurology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Clinical Neurology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.82LetPub ·
- CiteScore 2026-06
- 10.4LetPub ·
- SJR 2026-06
- 2.27LetPub ·
- SNIP 2026-06
- 1.52LetPub ·
- h-index
- 63OpenAlex ·
- i10-index
- 504OpenAlex ·
- 2-year mean citedness
- 6.66OpenAlex ·
- Self-citation rate
- 6%LetPub ·
- Share of gold OA articles
- 99.79%LetPub ·
Volume
- Articles per year
- 217LetPub ·
- Downloads per year (publisher) 2024
- 792,300Publisher website ·
Articles by year OpenAlex count · 1,324 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 216 | 216 | 200 |
| 2025 | 301 | 301 | 2,284 |
| 2024 | 170 | 170 | 2,092 |
| 2023 | 133 | 133 | 3,109 |
| 2022 | 109 | 109 | 3,709 |
| 2021 | 95 | 95 | 4,308 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
87 daysMedian, submission to acceptance · P25–P75 64 days – 135 days
- Acceptance to online
- median 14 days (85 articles)
- Submission to online
- median 106 days
- Sample
- 85 articles with submission and acceptance dates (474 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 3 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,060 / EUR 3,800 / GBP 3,250 / JPY 503,560 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open access publishing
To find out more about publishing your work Open Access in The Journal of Prevention of Alzheimer's Disease, including information on fees, funding and licences, visit our Open access publishing page.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- EDITIONS SERDI
- Country or region
- FRANCE
- Language
- English
- ISSN
- 2274-5807
- Electronic ISSN
- 2426-0266
- Latest issue on the website
- Volume 11, Issue 6 (December 2024)
- Official links
- Journal homepage ↗OpenAlex
- Special issues ↗Publisher website
FAQ
Frequently asked questions about JPAD-Journal of Prevention of Alzheimers Disease
What CAS zone is JPAD-Journal of Prevention of Alzheimers Disease in?
In the 2025 upgraded edition of the CAS Journal Ranking, JPAD-Journal of Prevention of Alzheimers Disease is in Zone 3 of Medicine, and in Zone 3 of the minor category Clinical Neurology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of JPAD-Journal of Prevention of Alzheimers Disease?
The latest impact factor listed by LetPub is 5.82; CiteScore 10.4, h-index 63.
How long does peer review take at JPAD-Journal of Prevention of Alzheimers Disease?
Based on the dates recorded on 85 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 87 days (interquartile range 64–135 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of JPAD-Journal of Prevention of Alzheimers Disease based?
Of the 19 board members whose country the journal's board page names, 1 (about 5%) are in mainland China; the countries named most often are United States (14), Mainland China (1) and France (1). Counted from the institutions listed on the board page; for reference only.
Which databases index JPAD-Journal of Prevention of Alzheimers Disease?
According to LetPub and DOAJ records, JPAD-Journal of Prevention of Alzheimers Disease is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, Embase and Current Contents; that list has not been checked against each database.
Is JPAD-Journal of Prevention of Alzheimers Disease open access, and what is the APC?
JPAD-Journal of Prevention of Alzheimers Disease is a fully open-access journal. APC about USD 4,060.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .